| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.005 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.006 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |